Healthcare

Recent updates from ASX healthcare stocks DXB and GLH

Highlights Dimerix recruits the first subject for its DMX-200 phase 3 trial in patients with FSGS kidney disease. FSGS has a huge market opportuni...

Mesoblast (ASX:MSB) posts US$23.1M third-quarter loss; how are share...

Highlights Mesoblast’s loss after tax for the third quarter FY2022 was US$21.3 million. Total revenue rose 5% from the comparative q...

CSL, RHC, SHL: 3 ASX health care stocks on investors’ watchlist  

Highlights CSL has the largest market capitalisation (AU$131.32 billion) in the ASX health care space as of 31 May 2022 In 2020/21, CSL invested U...

A look at 2 ASX-listed dental care stocks: SDI, PSQ

Highlights Private dental clinics cater to more than 85% of dental care in Australia. Dental care stock SDI, which registered record 1H sales, exp...

RAC, CTE, ADO: ASX health stocks with massive returns in past 3 year...

Multibaggers are lucrative stocks that provide returns several times higher than their initial investment value. To be more specific, if a stock price...

From REG to ICR: Latest updates from ASX-listed aged care stocks

Highlights The Australian government provides funding to a range of aged care homes Regis Healthcare provides care for over 7,200 people throughou...

Volpara Health (ASX:VHT) exceeds revenue guidance in FY22

Highlights Volpara marked 32% increase in revenue from customer contracts to NZ$26.1 million. Volpara delivered gross profit margin of over 91% in...

ALT and CDX: Why these ASX healthcare stocks were in news today

Highlights The S&P/ASX 200 Health Care (AXHJ) is up today with a gain of 0.235% Shares of ALT ended Wednesday with an upsurge of 50% followi...

WFL, OSL, AVE: Three ASX healthcare stocks with over 20% QTD returns

Highlights The Australian stock market closed on a higher note on Monday The benchmark of the ASX healthcare sector, S&P/ASX 200 Health Care,...

CSL’s (ASX: CSL) Vifor Pharma acquisition se to get delayed, shares...

Highlights CSL Limited share price drops about 1.69% by afternoon today (12 May, 1:PM AEST). CSL has warned of a delay in the Vifor pharma acquisi...

Beamtree (ASX:BMT) signs US$7M contract with Ampath; shares surge 

Highlights Beamtree has signed a five-year deal with Ampath for the implementation of its RippleDown software.  The total value of the contra...

PME, MDR, CSL: A look at three ASX healthcare growth stocks

Highlights Growth stocks are shares of the company estimated to increase sales and earnings faster than the market These stocks are likely to pr...

XPON subsidiary Wondaris expands reach by teaming up with Google CMU

Highlights XPN’s Wondaris platform has teamed up with Google’s CMU program The partnership will allow clients to upload high-value aud...

3D Printing: A great approach in healthcare innovations

Highlights 3D printing technology is used in developing new surgical cuttings, patient-specific replicas of bones, organs and blood vessels The...

Clinuvel (ASX:CUV) shares upbeat results from afamelanotide drug tri...

Highlights: CUV has received encouraging outcomes from the first clinical study assessing afamelanotide as a treatment for a life-threatening brain...

IPD, MX1 & MDR: Three ASX health tech stocks with strong revenue in...

Highlights ImpediMed saw record results for total revenue and SOZO SaaS revenue in Q3. Micro-X achieved good growth in Mobile DR unit sales with e...

AGN, PYC, KZA: An insight into key highlights of healthcare therapeu...

Highlights AGN continued preclinical work targeting the potential use of ARG-007 in other kinds of brain injuries PYC initiated GLP toxicology stu...

BOD (ASX:BOD) shares gain attention on quarterly update

Highlights BOD Australia has made solid progress towards the commencement of clinical trials and product commercialisation. Cannabis sales incre...

ResMed (ASX:RMD) revenue takes strong leap in FY22 third quarter

Highlights: ResMed released its unaudited Q3 FY22 results today, stating a 14% gain in revenue.  ResMed’s earnings per share stand at A...

Why is Starpharma (ASX:SPL) in news today?

Highlights: Starpharma is working closely with LloydsPharmacy to bring VIRALEZE back in the UK by this quarter. Starpharma has recorded AU$3.6 mil...